In a second study, Hyrenius-Wittsten et al. detected the tumour-specific antigen Alkaline Phosphatase Placental-like 2 (ALPPL2) as a specific target expressed in a variety of solid malignancies, including mesothelioma and ovarian cancer. This evidence concerns the gene ALPG and neoplasm.